Document Type
Presentation
Department
Oncology and Hematology
Abstract
Homologous Recombination Deficiency, Genetics, PARP Inhibitors, and Screening in Cancer, Amy Bodrog, MD, Lipson Cancer Institute
Objectives:
- Discuss how PARP inhibitors work.
- Discuss when screening for homologous recombination deficiency is appropriate.
Publication Date
10-19-2023
Recommended Citation
Bodrog, A. (2023). Homologous Recombination Deficiency, Genetics, PARP Inhibitors, and Screening in Cancer. Retrieved from https://scholar.rochesterregional.org/grandrounds_rgh/102
Error loading player: No playable sources found
COinS
